ID   JAK1_HUMAN              Reviewed;        1154 AA.
AC   P23458; Q59GQ2; Q9UD26;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   10-MAY-2017, entry version 191.
DE   RecName: Full=Tyrosine-protein kinase JAK1;
DE            EC=2.7.10.2 {ECO:0000269|PubMed:1848670, ECO:0000269|PubMed:7615558};
DE   AltName: Full=Janus kinase 1;
DE            Short=JAK-1;
GN   Name=JAK1; Synonyms=JAK1A, JAK1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CATALYTIC ACTIVITY.
RX   PubMed=1848670; DOI=10.1128/MCB.11.4.2057;
RA   Wilks A.F., Harpur A.G., Kurban R.R., Ralph S.J., Zuercher G.,
RA   Ziemiecki A.;
RT   "Two novel protein-tyrosine kinases, each with a second
RT   phosphotransferase-related catalytic domain, define a new class of
RT   protein kinase.";
RL   Mol. Cell. Biol. 11:2057-2065(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1005-1062.
RX   PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1008-1062, AND TISSUE SPECIFICITY.
RC   TISSUE=Colon tumor;
RX   PubMed=7896447; DOI=10.1002/ijc.2910600611;
RA   Craven R.J., Xu L.H., Weiner T.M., Fridell Y.-W., Dent G.A.,
RA   Srivastava S., Varnum B., Liu E.T., Cance W.G.;
RT   "Receptor tyrosine kinases expressed in metastatic colon cancer.";
RL   Int. J. Cancer 60:791-797(1995).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, INTERACTION WITH IFNGR1, AND
RP   PHOSPHORYLATION.
RX   PubMed=7615558; DOI=10.1074/jbc.270.29.17528;
RA   Sakatsume M., Igarashi K., Winestock K.D., Garotta G., Larner A.C.,
RA   Finbloom D.S.;
RT   "The Jak kinases differentially associate with the alpha and beta
RT   (accessory factor) chains of the interferon gamma receptor to form a
RT   functional receptor unit capable of activating STAT transcription
RT   factors.";
RL   J. Biol. Chem. 270:17528-17534(1995).
RN   [9]
RP   INTERACTION WITH IFNAR2.
RX   PubMed=7759950;
RA   Novick D., Cohen B., Tal N., Rubinstein M.;
RT   "Soluble and membrane-anchored forms of the human IFN-alpha/beta
RT   receptor.";
RL   J. Leukoc. Biol. 57:712-718(1995).
RN   [10]
RP   INTERACTION WITH SHB.
RX   PubMed=12200137; DOI=10.1016/S0006-291X(02)02016-8;
RA   Lindholm C.K.;
RT   "IL-2 receptor signaling through the Shb adapter protein in T and NK
RT   cells.";
RL   Biochem. Biophys. Res. Commun. 296:929-936(2002).
RN   [11]
RP   FUNCTION IN CYTOKINE SIGNALING, PHOSPHORYLATION AT TYR-1034 AND
RP   TYR-1035, AND DEPHOSPHORYLATION AT TYR-1034 AND TYR-1035 BY PTPN2.
RX   PubMed=11909529; DOI=10.1016/S0960-9822(02)00697-8;
RA   Simoncic P.D., Lee-Loy A., Barber D.L., Tremblay M.L., McGlade C.J.;
RT   "The T cell protein tyrosine phosphatase is a negative regulator of
RT   janus family kinases 1 and 3.";
RL   Curr. Biol. 12:446-453(2002).
RN   [12]
RP   INTERACTION WITH IL31RA.
RX   PubMed=15194700; DOI=10.1074/jbc.M401122200;
RA   Dreuw A., Radtke S., Pflanz S., Lippok B.E., Heinrich P.C.,
RA   Hermanns H.M.;
RT   "Characterization of the signaling capacities of the novel gp130-like
RT   cytokine receptor.";
RL   J. Biol. Chem. 279:36112-36120(2004).
RN   [13]
RP   INTERACTION WITH JAKMIP1.
RX   PubMed=15277531; DOI=10.1074/jbc.M401915200;
RA   Steindler C., Li Z., Algarte M., Alcover A., Libri V., Ragimbeau J.,
RA   Pellegrini S.;
RT   "Jamip1 (marlin-1) defines a family of proteins interacting with Janus
RT   kinases and microtubules.";
RL   J. Biol. Chem. 279:43168-43177(2004).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT TYR-3 AND SER-228, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   UBIQUITINATION.
RX   PubMed=26027934; DOI=10.1016/j.celrep.2015.04.049;
RA   Kim H., Frederick D.T., Levesque M.P., Cooper Z.A., Feng Y.,
RA   Krepler C., Brill L., Samuels Y., Hayward N.K., Perlina A., Piris A.,
RA   Zhang T., Halaban R., Herlyn M.M., Brown K.M., Wargo J.A., Dummer R.,
RA   Flaherty K.T., Ronai Z.A.;
RT   "Downregulation of the ubiquitin ligase RNF125 underlies resistance of
RT   melanoma cells to BRAF inhibitors via JAK1 deregulation.";
RL   Cell Rep. 11:1458-1473(2015).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 865-1154 IN COMPLEXES WITH
RP   SYNTHETIC INHIBITORS CMP6 AND CP-690,550.
RX   PubMed=19361440; DOI=10.1016/j.jmb.2009.01.041;
RA   Williams N.K., Bamert R.S., Patel O., Wang C., Walden P.M.,
RA   Wilks A.F., Fantino E., Rossjohn J., Lucet I.S.;
RT   "Dissecting specificity in the Janus kinases: the structures of JAK-
RT   specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine
RT   kinase domains.";
RL   J. Mol. Biol. 387:219-232(2009).
RN   [19]
RP   VARIANT [LARGE SCALE ANALYSIS] LYS-973.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Tyrosine kinase of the non-receptor type, involved in
CC       the IFN-alpha/beta/gamma signal pathway (PubMed:7615558). Kinase
CC       partner for the interleukin (IL)-2 receptor (PubMed:11909529).
CC       {ECO:0000269|PubMed:11909529, ECO:0000269|PubMed:7615558}.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate. {ECO:0000255|PROSITE-
CC       ProRule:PRU10028, ECO:0000269|PubMed:1848670,
CC       ECO:0000269|PubMed:7615558}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000305|PubMed:7615558};
CC       Note=Mn(2+) was used in the in vitro kinase assay but Mg(2+) is
CC       likely to be the in vivo cofactor. {ECO:0000305|PubMed:7615558};
CC   -!- SUBUNIT: Interacts with IL31RA (PubMed:15194700). Interacts with
CC       IFNAR2 (PubMed:7759950). Interacts with IFNGR1 (PubMed:7615558).
CC       Interacts with JAKMIP1 (PubMed:15277531). Interacts with SHB
CC       (PubMed:12200137). Interacts with FER (By similarity).
CC       {ECO:0000250|UniProtKB:P52332, ECO:0000269|PubMed:12200137,
CC       ECO:0000269|PubMed:15194700, ECO:0000269|PubMed:15277531,
CC       ECO:0000269|PubMed:7615558, ECO:0000269|PubMed:7759950}.
CC   -!- INTERACTION:
CC       P04626:ERBB2; NbExp=2; IntAct=EBI-1383438, EBI-641062;
CC       P48551:IFNAR2; NbExp=3; IntAct=EBI-1383438, EBI-958408;
CC   -!- SUBCELLULAR LOCATION: Endomembrane system; Peripheral membrane
CC       protein. Note=Wholly intracellular, possibly membrane associated.
CC   -!- TISSUE SPECIFICITY: Expressed at higher levels in primary colon
CC       tumors than in normal colon tissue. The expression level in
CC       metastatic colon tumors is comparable to the expression level in
CC       normal colon tissue. {ECO:0000269|PubMed:7896447}.
CC   -!- DOMAIN: Possesses two phosphotransferase domains. The second one
CC       probably contains the catalytic domain, while the presence of
CC       slight differences suggest a different role for domain 1.
CC       {ECO:0000250}.
CC   -!- DOMAIN: The FERM domain mediates interaction with JAKMIP1.
CC   -!- PTM: Autophosphorylated (PubMed:7615558). Phosphorylated on
CC       tyrosine residues in response to interferon gamma signaling
CC       (PubMed:7615558). Dephosphorylation of Tyr-1034 and Tyr-1035 by
CC       PTPN2 negatively regulates cytokine-mediated signaling
CC       (PubMed:11909529). {ECO:0000269|PubMed:11909529,
CC       ECO:0000269|PubMed:7615558}.
CC   -!- PTM: Ubiquitinated by RNF125; leading to its degradation by the
CC       proteasome. {ECO:0000269|PubMed:26027934}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. JAK subfamily. {ECO:0000255|PROSITE-
CC       ProRule:PRU00159}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA36527.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAA36527.1; Type=Frameshift; Positions=858, 862; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/JAK1ID41031ch1p31.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M64174; AAA36527.1; ALT_SEQ; mRNA.
DR   EMBL; AB209057; BAD92294.1; -; mRNA.
DR   EMBL; AC093427; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06547.1; -; Genomic_DNA.
DR   EMBL; BC132729; AAI32730.1; -; mRNA.
DR   CCDS; CCDS41346.1; -.
DR   PIR; A39577; A39577.
DR   RefSeq; NP_001307852.1; NM_001320923.1.
DR   RefSeq; NP_001308781.1; NM_001321852.1.
DR   RefSeq; NP_001308782.1; NM_001321853.1.
DR   RefSeq; NP_001308783.1; NM_001321854.1.
DR   RefSeq; NP_001308784.1; NM_001321855.1.
DR   RefSeq; NP_001308785.1; NM_001321856.1.
DR   RefSeq; NP_002218.2; NM_002227.3.
DR   UniGene; Hs.207538; -.
DR   PDB; 3EYG; X-ray; 1.90 A; A=865-1154.
DR   PDB; 3EYH; X-ray; 2.00 A; A=865-1154.
DR   PDB; 4E4L; X-ray; 2.00 A; A/B/D/E=854-1154.
DR   PDB; 4E4N; X-ray; 1.90 A; A/B=854-1154.
DR   PDB; 4E5W; X-ray; 1.86 A; A/B=854-1154.
DR   PDB; 4EHZ; X-ray; 2.17 A; A/B/C/D=854-1154.
DR   PDB; 4EI4; X-ray; 2.22 A; A/B=854-1154.
DR   PDB; 4FK6; X-ray; 2.20 A; A/B=854-1154.
DR   PDB; 4GS0; X-ray; 1.80 A; C=1033-1036.
DR   PDB; 4I5C; X-ray; 2.10 A; A/B=854-1154.
DR   PDB; 4IVB; X-ray; 1.90 A; A/B=854-1154.
DR   PDB; 4IVC; X-ray; 2.35 A; A/B=854-1154.
DR   PDB; 4IVD; X-ray; 1.93 A; A/B=854-1154.
DR   PDB; 4K6Z; X-ray; 2.73 A; A=854-1154.
DR   PDB; 4K77; X-ray; 2.40 A; A/B=854-1154.
DR   PDB; 4L00; X-ray; 1.80 A; A/B=561-860.
DR   PDB; 4L01; X-ray; 1.90 A; A/B=561-860.
DR   PDB; 5E1E; X-ray; 2.30 A; A/B=865-1154.
DR   PDB; 5HX8; X-ray; 2.20 A; A/B=854-1154.
DR   PDB; 5IXD; X-ray; 2.85 A; A=35-559.
DR   PDB; 5IXI; X-ray; 2.57 A; A=35-559.
DR   PDB; 5KHW; X-ray; 2.47 A; A/B=841-1154.
DR   PDB; 5KHX; X-ray; 2.40 A; A=841-1154.
DR   PDB; 5L04; X-ray; 2.10 A; A=31-577.
DR   PDBsum; 3EYG; -.
DR   PDBsum; 3EYH; -.
DR   PDBsum; 4E4L; -.
DR   PDBsum; 4E4N; -.
DR   PDBsum; 4E5W; -.
DR   PDBsum; 4EHZ; -.
DR   PDBsum; 4EI4; -.
DR   PDBsum; 4FK6; -.
DR   PDBsum; 4GS0; -.
DR   PDBsum; 4I5C; -.
DR   PDBsum; 4IVB; -.
DR   PDBsum; 4IVC; -.
DR   PDBsum; 4IVD; -.
DR   PDBsum; 4K6Z; -.
DR   PDBsum; 4K77; -.
DR   PDBsum; 4L00; -.
DR   PDBsum; 4L01; -.
DR   PDBsum; 5E1E; -.
DR   PDBsum; 5HX8; -.
DR   PDBsum; 5IXD; -.
DR   PDBsum; 5IXI; -.
DR   PDBsum; 5KHW; -.
DR   PDBsum; 5KHX; -.
DR   PDBsum; 5L04; -.
DR   ProteinModelPortal; P23458; -.
DR   SMR; P23458; -.
DR   BioGrid; 109919; 97.
DR   DIP; DIP-133N; -.
DR   IntAct; P23458; 49.
DR   MINT; MINT-145830; -.
DR   STRING; 9606.ENSP00000343204; -.
DR   BindingDB; P23458; -.
DR   ChEMBL; CHEMBL2835; -.
DR   DrugBank; DB08877; Ruxolitinib.
DR   DrugBank; DB08895; Tofacitinib.
DR   GuidetoPHARMACOLOGY; 2047; -.
DR   iPTMnet; P23458; -.
DR   PhosphoSitePlus; P23458; -.
DR   SwissPalm; P23458; -.
DR   BioMuta; JAK1; -.
DR   DMDM; 215274013; -.
DR   EPD; P23458; -.
DR   MaxQB; P23458; -.
DR   PaxDb; P23458; -.
DR   PeptideAtlas; P23458; -.
DR   PRIDE; P23458; -.
DR   Ensembl; ENST00000342505; ENSP00000343204; ENSG00000162434.
DR   GeneID; 3716; -.
DR   KEGG; hsa:3716; -.
DR   UCSC; uc001dbu.2; human.
DR   CTD; 3716; -.
DR   DisGeNET; 3716; -.
DR   GeneCards; JAK1; -.
DR   HGNC; HGNC:6190; JAK1.
DR   HPA; CAB013088; -.
DR   MIM; 147795; gene.
DR   neXtProt; NX_P23458; -.
DR   OpenTargets; ENSG00000162434; -.
DR   PharmGKB; PA29988; -.
DR   eggNOG; KOG0197; Eukaryota.
DR   eggNOG; COG0515; LUCA.
DR   GeneTree; ENSGT00760000118799; -.
DR   HOGENOM; HOG000049158; -.
DR   HOVERGEN; HBG006195; -.
DR   InParanoid; P23458; -.
DR   KO; K11217; -.
DR   OMA; PLDLFMH; -.
DR   OrthoDB; EOG091G01IS; -.
DR   PhylomeDB; P23458; -.
DR   TreeFam; TF327041; -.
DR   BRENDA; 2.7.10.2; 2681.
DR   Reactome; R-HSA-1059683; Interleukin-6 signaling.
DR   Reactome; R-HSA-110056; MAPK3 (ERK1) activation.
DR   Reactome; R-HSA-112411; MAPK1 (ERK2) activation.
DR   Reactome; R-HSA-114604; GPVI-mediated activation cascade.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-1266695; Interleukin-7 signaling.
DR   Reactome; R-HSA-392451; G beta:gamma signalling through PI3Kgamma.
DR   Reactome; R-HSA-451927; Interleukin-2 signaling.
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-6785807; Interleukin-4 and 13 signaling.
DR   Reactome; R-HSA-6788467; IL-6-type cytokine receptor ligand interactions.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-877312; Regulation of IFNG signaling.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   Reactome; R-HSA-912526; Interleukin receptor SHC signaling.
DR   Reactome; R-HSA-912694; Regulation of IFNA signaling.
DR   SignaLink; P23458; -.
DR   SIGNOR; P23458; -.
DR   ChiTaRS; JAK1; human.
DR   EvolutionaryTrace; P23458; -.
DR   GeneWiki; Janus_kinase_1; -.
DR   GenomeRNAi; 3716; -.
DR   PRO; PR:P23458; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000162434; -.
DR   CleanEx; HS_JAK1; -.
DR   Genevisible; P23458; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:BHF-UCL.
DR   GO; GO:0005856; C:cytoskeleton; IEA:InterPro.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0012505; C:endomembrane system; IEA:UniProtKB-SubCell.
DR   GO; GO:0031234; C:extrinsic component of cytoplasmic side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0005925; C:focal adhesion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0031730; F:CCR5 chemokine receptor binding; IEA:Ensembl.
DR   GO; GO:0005131; F:growth hormone receptor binding; ISS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0019903; F:protein phosphatase binding; IPI:UniProtKB.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; EXP:Reactome.
DR   GO; GO:0005088; F:Ras guanyl-nucleotide exchange factor activity; TAS:Reactome.
DR   GO; GO:0005102; F:receptor binding; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0016477; P:cell migration; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; IBA:GO_Central.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0038110; P:interleukin-2-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0038083; P:peptidyl-tyrosine autophosphorylation; IBA:GO_Central.
DR   GO; GO:1903672; P:positive regulation of sprouting angiogenesis; IGI:BHF-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; TAS:ProtInc.
DR   GO; GO:0042127; P:regulation of cell proliferation; IBA:GO_Central.
DR   GO; GO:0060334; P:regulation of interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0060338; P:regulation of type I interferon-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0046677; P:response to antibiotic; IDA:MGI.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IBA:GO_Central.
DR   GO; GO:0060337; P:type I interferon signaling pathway; TAS:Reactome.
DR   Gene3D; 1.20.80.10; -; 1.
DR   Gene3D; 3.30.505.10; -; 1.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR011993; PH_dom-like.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR000980; SH2.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   InterPro; IPR020635; Tyr_kinase_cat_dom.
DR   InterPro; IPR016251; Tyr_kinase_non-rcpt_Jak/Tyk2.
DR   InterPro; IPR020776; Tyr_kinase_non-rcpt_Jak1.
DR   Pfam; PF07714; Pkinase_Tyr; 2.
DR   PIRSF; PIRSF000636; TyrPK_Jak; 1.
DR   PRINTS; PR01823; JANUSKINASE.
DR   PRINTS; PR01824; JANUSKINASE1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00252; SH2; 1.
DR   SMART; SM00219; TyrKc; 2.
DR   SUPFAM; SSF47031; SSF47031; 1.
DR   SUPFAM; SSF50729; SSF50729; 1.
DR   SUPFAM; SSF55550; SSF55550; 1.
DR   SUPFAM; SSF56112; SSF56112; 2.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 2.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
DR   PROSITE; PS50001; SH2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Complete proteome; Kinase;
KW   Magnesium; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; SH2 domain;
KW   Transferase; Tyrosine-protein kinase; Ubl conjugation.
FT   CHAIN         1   1154       Tyrosine-protein kinase JAK1.
FT                                /FTId=PRO_0000088108.
FT   DOMAIN       34    420       FERM. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00084}.
FT   DOMAIN      439    544       SH2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00191}.
FT   DOMAIN      583    855       Protein kinase 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      875   1153       Protein kinase 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND     881    889       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE   1003   1003       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10028}.
FT   BINDING     908    908       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES       3      3       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     228    228       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES    1034   1034       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11909529}.
FT   MOD_RES    1035   1035       Phosphotyrosine; by autocatalysis.
FT                                {ECO:0000269|PubMed:11909529}.
FT   VARIANT     973    973       N -> K (in dbSNP:rs34680086).
FT                                {ECO:0000269|PubMed:17344846}.
FT                                /FTId=VAR_041715.
FT   CONFLICT    350    350       H -> D (in Ref. 1; AAA36527).
FT                                {ECO:0000305}.
FT   CONFLICT    368    368       Y -> F (in Ref. 1; AAA36527).
FT                                {ECO:0000305}.
FT   CONFLICT    898    898       Missing (in Ref. 1; AAA36527).
FT                                {ECO:0000305}.
FT   STRAND       36     39       {ECO:0000244|PDB:5L04}.
FT   STRAND       43     45       {ECO:0000244|PDB:5IXI}.
FT   STRAND       48     50       {ECO:0000244|PDB:5L04}.
FT   STRAND       52     56       {ECO:0000244|PDB:5L04}.
FT   HELIX        57     67       {ECO:0000244|PDB:5L04}.
FT   TURN         72     74       {ECO:0000244|PDB:5L04}.
FT   HELIX        75     77       {ECO:0000244|PDB:5L04}.
FT   STRAND       78     82       {ECO:0000244|PDB:5L04}.
FT   TURN         83     86       {ECO:0000244|PDB:5L04}.
FT   STRAND       94     97       {ECO:0000244|PDB:5L04}.
FT   STRAND      103    109       {ECO:0000244|PDB:5L04}.
FT   TURN        114    117       {ECO:0000244|PDB:5L04}.
FT   STRAND      121    123       {ECO:0000244|PDB:5IXI}.
FT   STRAND      149    151       {ECO:0000244|PDB:5L04}.
FT   HELIX       152    167       {ECO:0000244|PDB:5L04}.
FT   HELIX       179    204       {ECO:0000244|PDB:5L04}.
FT   TURN        208    210       {ECO:0000244|PDB:5IXD}.
FT   HELIX       217    220       {ECO:0000244|PDB:5L04}.
FT   HELIX       223    230       {ECO:0000244|PDB:5L04}.
FT   HELIX       234    252       {ECO:0000244|PDB:5L04}.
FT   HELIX       254    259       {ECO:0000244|PDB:5L04}.
FT   HELIX       263    277       {ECO:0000244|PDB:5L04}.
FT   STRAND      278    280       {ECO:0000244|PDB:5L04}.
FT   STRAND      284    289       {ECO:0000244|PDB:5L04}.
FT   STRAND      291    293       {ECO:0000244|PDB:5L04}.
FT   STRAND      299    304       {ECO:0000244|PDB:5IXI}.
FT   STRAND      313    318       {ECO:0000244|PDB:5L04}.
FT   TURN        319    321       {ECO:0000244|PDB:5L04}.
FT   STRAND      322    327       {ECO:0000244|PDB:5L04}.
FT   STRAND      364    367       {ECO:0000244|PDB:5L04}.
FT   HELIX       369    371       {ECO:0000244|PDB:5L04}.
FT   STRAND      372    378       {ECO:0000244|PDB:5L04}.
FT   STRAND      381    386       {ECO:0000244|PDB:5L04}.
FT   STRAND      391    395       {ECO:0000244|PDB:5L04}.
FT   HELIX       399    416       {ECO:0000244|PDB:5L04}.
FT   HELIX       425    427       {ECO:0000244|PDB:5L04}.
FT   HELIX       430    437       {ECO:0000244|PDB:5L04}.
FT   HELIX       446    456       {ECO:0000244|PDB:5L04}.
FT   STRAND      463    467       {ECO:0000244|PDB:5L04}.
FT   STRAND      472    482       {ECO:0000244|PDB:5L04}.
FT   STRAND      493    503       {ECO:0000244|PDB:5L04}.
FT   STRAND      506    509       {ECO:0000244|PDB:5L04}.
FT   STRAND      516    518       {ECO:0000244|PDB:5L04}.
FT   HELIX       519    527       {ECO:0000244|PDB:5L04}.
FT   STRAND      529    533       {ECO:0000244|PDB:5L04}.
FT   STRAND      536    538       {ECO:0000244|PDB:5L04}.
FT   STRAND      555    557       {ECO:0000244|PDB:5L04}.
FT   HELIX       559    562       {ECO:0000244|PDB:5L04}.
FT   HELIX       569    572       {ECO:0000244|PDB:4L00}.
FT   STRAND      575    578       {ECO:0000244|PDB:4L00}.
FT   HELIX       580    582       {ECO:0000244|PDB:4L00}.
FT   STRAND      583    592       {ECO:0000244|PDB:4L00}.
FT   STRAND      595    603       {ECO:0000244|PDB:4L00}.
FT   STRAND      616    624       {ECO:0000244|PDB:4L00}.
FT   HELIX       629    644       {ECO:0000244|PDB:4L00}.
FT   STRAND      653    659       {ECO:0000244|PDB:4L00}.
FT   STRAND      662    668       {ECO:0000244|PDB:4L00}.
FT   HELIX       675    682       {ECO:0000244|PDB:4L00}.
FT   TURN        683    685       {ECO:0000244|PDB:4L00}.
FT   HELIX       688    707       {ECO:0000244|PDB:4L00}.
FT   HELIX       717    719       {ECO:0000244|PDB:4L00}.
FT   STRAND      720    724       {ECO:0000244|PDB:4L00}.
FT   STRAND      727    731       {ECO:0000244|PDB:4L00}.
FT   STRAND      734    737       {ECO:0000244|PDB:4L00}.
FT   HELIX       744    746       {ECO:0000244|PDB:4L00}.
FT   HELIX       749    754       {ECO:0000244|PDB:4L00}.
FT   TURN        755    758       {ECO:0000244|PDB:4L00}.
FT   HELIX       761    765       {ECO:0000244|PDB:4L00}.
FT   HELIX       767    769       {ECO:0000244|PDB:4L00}.
FT   HELIX       774    787       {ECO:0000244|PDB:4L00}.
FT   TURN        788    790       {ECO:0000244|PDB:4L00}.
FT   TURN        793    796       {ECO:0000244|PDB:4L00}.
FT   HELIX       799    807       {ECO:0000244|PDB:4L00}.
FT   HELIX       818    827       {ECO:0000244|PDB:4L00}.
FT   HELIX       832    834       {ECO:0000244|PDB:4L00}.
FT   HELIX       838    848       {ECO:0000244|PDB:4L00}.
FT   HELIX       872    874       {ECO:0000244|PDB:4E5W}.
FT   STRAND      875    883       {ECO:0000244|PDB:4E5W}.
FT   STRAND      885    894       {ECO:0000244|PDB:4E5W}.
FT   STRAND      898    900       {ECO:0000244|PDB:4E5W}.
FT   STRAND      902    910       {ECO:0000244|PDB:4E5W}.
FT   HELIX       919    930       {ECO:0000244|PDB:4E5W}.
FT   STRAND      940    945       {ECO:0000244|PDB:4E5W}.
FT   TURN        947    950       {ECO:0000244|PDB:5KHX}.
FT   STRAND      952    957       {ECO:0000244|PDB:4E5W}.
FT   HELIX       964    971       {ECO:0000244|PDB:4E5W}.
FT   TURN        972    974       {ECO:0000244|PDB:4E5W}.
FT   HELIX       977    996       {ECO:0000244|PDB:4E5W}.
FT   STRAND      998   1000       {ECO:0000244|PDB:4K6Z}.
FT   HELIX      1006   1008       {ECO:0000244|PDB:4E5W}.
FT   STRAND     1009   1013       {ECO:0000244|PDB:4E5W}.
FT   STRAND     1016   1019       {ECO:0000244|PDB:4E5W}.
FT   STRAND     1034   1036       {ECO:0000244|PDB:4E5W}.
FT   STRAND     1039   1041       {ECO:0000244|PDB:5KHX}.
FT   HELIX      1045   1047       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1050   1055       {ECO:0000244|PDB:4E5W}.
FT   STRAND     1057   1059       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1060   1075       {ECO:0000244|PDB:4E5W}.
FT   TURN       1076   1078       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1080   1082       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1084   1092       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1097   1099       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1100   1109       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1122   1130       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1136   1138       {ECO:0000244|PDB:4E5W}.
FT   HELIX      1142   1153       {ECO:0000244|PDB:4E5W}.
SQ   SEQUENCE   1154 AA;  133277 MW;  A2C4BE27851ACABB CRC64;
     MQYLNIKEDC NAMAFCAKMR SSKKTEVNLE APEPGVEVIF YLSDREPLRL GSGEYTAEEL
     CIRAAQACRI SPLCHNLFAL YDENTKLWYA PNRTITVDDK MSLRLHYRMR FYFTNWHGTN
     DNEQSVWRHS PKKQKNGYEK KKIPDATPLL DASSLEYLFA QGQYDLVKCL APIRDPKTEQ
     DGHDIENECL GMAVLAISHY AMMKKMQLPE LPKDISYKRY IPETLNKSIR QRNLLTRMRI
     NNVFKDFLKE FNNKTICDSS VSTHDLKVKY LATLETLTKH YGAEIFETSM LLISSENEMN
     WFHSNDGGNV LYYEVMVTGN LGIQWRHKPN VVSVEKEKNK LKRKKLENKH KKDEEKNKIR
     EEWNNFSYFP EITHIVIKES VVSINKQDNK KMELKLSSHE EALSFVSLVD GYFRLTADAH
     HYLCTDVAPP LIVHNIQNGC HGPICTEYAI NKLRQEGSEE GMYVLRWSCT DFDNILMTVT
     CFEKSEQVQG AQKQFKNFQI EVQKGRYSLH GSDRSFPSLG DLMSHLKKQI LRTDNISFML
     KRCCQPKPRE ISNLLVATKK AQEWQPVYPM SQLSFDRILK KDLVQGEHLG RGTRTHIYSG
     TLMDYKDDEG TSEEKKIKVI LKVLDPSHRD ISLAFFEAAS MMRQVSHKHI VYLYGVCVRD
     VENIMVEEFV EGGPLDLFMH RKSDVLTTPW KFKVAKQLAS ALSYLEDKDL VHGNVCTKNL
     LLAREGIDSE CGPFIKLSDP GIPITVLSRQ ECIERIPWIA PECVEDSKNL SVAADKWSFG
     TTLWEICYNG EIPLKDKTLI EKERFYESRC RPVTPSCKEL ADLMTRCMNY DPNQRPFFRA
     IMRDINKLEE QNPDIVSEKK PATEVDPTHF EKRFLKRIRD LGEGHFGKVE LCRYDPEGDN
     TGEQVAVKSL KPESGGNHIA DLKKEIEILR NLYHENIVKY KGICTEDGGN GIKLIMEFLP
     SGSLKEYLPK NKNKINLKQQ LKYAVQICKG MDYLGSRQYV HRDLAARNVL VESEHQVKIG
     DFGLTKAIET DKEYYTVKDD RDSPVFWYAP ECLMQSKFYI ASDVWSFGVT LHELLTYCDS
     DSSPMALFLK MIGPTHGQMT VTRLVNTLKE GKRLPCPPNC PDEVYQLMRK CWEFQPSNRT
     SFQNLIEGFE ALLK
//
